top of page

Cleerly’s James Min talks about heart disease and improving cardiovascular imaging at #HLTH2023

  • blonca9
  • Oct 8, 2023
  • 1 min read

Dr. Min describes how Cleerly’s technology is designed to improve how CT scans are analyzed, and how the company aims to move upstream from symptomatic disease to doing asymptomatic screening as well.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTVHQ

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Genezen_Logo_RGB.png

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

Learn more about Genezen

bottom of page